Immune Predictors of Response after Bacillus <i>Calmette–Guérin</i> Treatment in Non-Muscle-Invasive Bladder Cancer

Immune Predictors of Response after Bacillus <i>Calmette–Guérin</i> Treatment in Non-Muscle-Invasive Bladder Cancer

Bacillus Calmette–Guérin (BCG) has been the standard of care for the treatment of high-risk, non-muscle-invasive bladder cancer (NMIBC) for decades, but 49.6% of high-risk and very-high-risk patients will experience progression to muscle-invasive disease in five years. Furthermore, cytology and cyst...

Full description

Bibliographic Details
Main Authors: Marta Rodríguez-Izquierdo, Carmen G. Del Cañizo, Carolina Rubio, Ignacio A. Reina, Mario Hernández Arroyo, Alfredo Rodríguez Antolín, Marta Dueñas Porto, Félix Guerrero-Ramos
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
bladder cancer
Bacillus <i>Calmette–Guérin</i>
cytokines
tumor microenvironment
immune response
Online Access:https://www.mdpi.com/2072-6694/15/23/5554

Internet

https://www.mdpi.com/2072-6694/15/23/5554

Similar Items